{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"pparg-related-familial-partial-lipodystrophy","columns":[{"gene":"","key":"population-f044b3be35fe8651553b","label":"Lipodystrophy, familial partial, type 3","mondoId":"MONDO:0011448","onsetQualifier":null,"originColumnKey":"MONDO:0011448/OMIM:604367","originalViews":[{"key":"MONDO:0011448/OMIM:604367","label":"Lipodystrophy, familial partial, type 3","scopeLabel":"OMIM:604367","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["01bd405ba26ae24d6f6fbec9586f9fb8f23ceeed9bf5579299b689b27e296d72","039da1492fd4610793b311629f1261a4edfabbc8b564ef844bc8c2f30df34e12","114f45ff29ae1795768ae64658a36505d8b7007c0fa71daf46b765067e0eff53","1b6c2316e23ba1dac8a92f35b71fba260569e939c4a662ab4d413605174bc676","2474e3b860fd0693f4bfafe96079d3a62114ec1e9a583e775d99c133a2ef944d","2be79e3c2e0e235672a24d6caa3b01674a65ac45c1bce5dc86c410c391b1c70f","4eff4ceb5694714174fea13ba86f6ec4449cc43a1feaac5e0be1a28af2a073c7","5a67bc9c4fd51236fa49a121ec7ae927f2274d7f26c50dfae8db336ecd3c2098","77b948ffc5ef92a3112e84b2ecb7cb87ee05b862d69f93bba899f332390c59fd","918bb526bade91926f489b62dc52838777b587a1ed9ca89634226e0d1aeec6d7","a079aae021ff10d627ed2bc0f1f1064b0232d4b35bea2ced36f8dda0b72d2888","a09247752a126c7f6b4a45686cdcfd1ad4c637c9102d71e06052f766e46981ea","a25c8610ac3de6600801023220e18e3a488d42f9e9b77fd8ffa1841fedf09a6e","a84f7616991c8ed03dc74d602411821ce8945d67af77efdacc6435a9b03bc290","a971afd937503c7df8bdedb9a73d4df023468af59e44aa900d31bac1af93bbc0","b1c78c8bd99080fb1b663174749bbf2a0468e810a0b1effbd4436332bdceeb0d","b670feebb645eadffda03809de0dd4c08731069042ac12dfbd939694c7156039","c0fb4b9fd4b30dbd2ac1a24bdbe09a3af161efb5e751f5fa6afcec3894977975","cca44d37ac910aad8fc61c0e71469a89965e79b7d01d354bbd90dd8019e4d1ca","e081feec23e3f1c4792e73ac452180a512cb238d41df6919af430e584f5f1ead","e12eb4b393614d9d67c62d0cb2fd66208c6065b94a71b611f31e931cb37dfb51"],"recordQualifiers":{},"scopeLabel":"OMIM:604367","sourceIds":["OMIM:604367"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."},{"gene":"","key":"population-64c4c6b14bd39d97032f","label":"PPARG-related familial partial lipodystrophy","mondoId":"MONDO:0011448","onsetQualifier":null,"originColumnKey":"MONDO:0011448/ORPHA:79083","originalViews":[{"key":"MONDO:0011448/ORPHA:79083","label":"PPARG-related familial partial lipodystrophy","scopeLabel":"ORPHA:79083","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["06d9e889f2dcd9815dbd68bb1f4786cda2dfea921189c40a56c8a418eb3067c5","091c38c41b0464bdea66f5e4181287c54c9861293db5e7ff57ec6d3c79a932f4","104960cc32aab18eed246a00f2de5cb2efcbf9f1a0801d49a7b41b5363c1236c","17682b1d1c32a9fe55e5f8fd94ddbda8e7faad0dd033c1cf3a4a08b54887a4a1","1edf2071880c596516a9ddaf5f735129e1ce31aa6818280fe4d41002d215e132","1f880368316f8fe8aeb18600996f30d9f5f8c716efcdc71745be4780426e6d87","2135226b5bb9423e580b6afa227d4da02cd1b74e49d889b98747f84561fb92a8","286a6550c66e467b493833a7543a825aab4963f204c8282f602eacf9b9f81dc3","2ccda969b0763b1f2469b83c024cd8272aca3a31c3f293336a19f609f9b59f3c","2e5d2680bbc77df96cc4f1c39bd0cecda84f9f995b31cbc6f2398e60f46ae11d","35b28628a38c619e11c5a2d0f7ec771d45ea0c3c642c16c06b37414d645f8fcd","5428c25f75ad37a3491a18b087715e141d34b9c70fa28ae69f8fb9e6a35d5f04","63b8974bf0e46301a3d1710ea5e5654e2d4bfbcb4ef62ff902e51096d16f6a56","67a8d34a5754e86f4f4d32b22884a3d475c80c81fd5f59bb9532b1537e97ca70","70ebbd641a9bbdffe0f2bc7b52060175826bf57a5c766f928306f4b7d3afd619","725d1e98cd3e87955c2e19b39300cb914780a8437c4fe7c03d907c1600745b39","8e8b2f3661644cfd9dcbcd449552c7b765ca2ce08c08b1e607c74bcc16511a1e","96aea37ed13dc81c692c7aa7c74c9b6a4e7839684d63329a55c62cb1823ec63f","9be9f9aca39d7cbbd8d3b3beb21546f9bfb6f899c6743ea56f56d0c02d9641d7","9f7daaeea4dc5a728eda818ae68a943b4f9ba69dddf5bcb4552d3a5498fa0e20","a58d13c7fe0f7eac3e492b704a58016ff4a133022c07db42f689b5cf26fb6a82","a70bf04bfa9281394190d33f67a9757eeef3ca5977724568036e87e101f14770","a7614a1ff0160e40842fa7b9509409e10a5e22005f9ed7de0e6dce0e6e8c575d","b0957fc099b4e18771b27f685f2927d8c9bc3c423637c994c4b16eda7c8a198e","b15f4321743b20caefada1e9f4615d4136e72317c0fbb910ecd65042afbe0345","b33d8bfd15095244997f68970feb08800a22f5dbec0bbe133d65b309d0aad9a0","bdef78f9549d6cf6d625cea6d1c82a43d7505d99b469b403da44257b1a87739e","e2aced6f2aeee2e1c2a2828ef09dfaa0a120a0245265111b2ddb06d29a9188ee","e7d4949cebf9365d07728cd8a4408cf38576135b85853d11ca5f4ad61d4a9ae6","f819cc40be6b33af77e7366eb46b9e9964f40d3f8ad7cf850d8fc744e7a28120","f9415006beee712f4b23bd78619982ee8ab60854bd6d48ee02972c64f688080d","fb0d571f868d4bc6c4e0a8083b406338e8e0ebbfe4cfa330631c6a962dbede81","fbc6dc1611116d3f72402396dab386daabc569424f647b5271e5e83bc134e0be","fc870822c146f97b04590fa599c4f242531380e132623554626760b9f33cecca"],"recordQualifiers":{},"scopeLabel":"ORPHA:79083","sourceIds":["ORPHA:79083"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-f044b3be35fe8651553b","population-64c4c6b14bd39d97032f"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0012084","HP:0000956","HP:0008065","HP:0002621","HP:0003707","HP:0001394","HP:0001635"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":11,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":55,"sourceGroups":{"omim":10,"orphanet":34,"published":11}},"features":[{"hpoId":"HP:0012084","label":"Abnormality of skeletal muscle fiber size","primary":true},{"hpoId":"HP:0000956","label":"Acanthosis nigricans","primary":true},{"hpoId":"HP:0008065","label":"Aplasia/Hypoplasia of the skin","primary":true},{"hpoId":"HP:0002621","label":"Atherosclerosis","primary":true},{"hpoId":"HP:0003707","label":"Calf muscle pseudohypertrophy","primary":true},{"hpoId":"HP:0001394","label":"Cirrhosis","primary":true},{"hpoId":"HP:0001635","label":"Congestive heart failure","primary":true},{"hpoId":"HP:0001677","label":"Coronary artery atherosclerosis","primary":false},{"hpoId":"HP:0003233","label":"Decreased circulating HDL-C concentration","primary":false},{"hpoId":"HP:0000819","label":"Diabetes mellitus","primary":false},{"hpoId":"HP:0100607","label":"Dysmenorrhea","primary":false},{"hpoId":"HP:0002230","label":"Generalized hirsutism","primary":false},{"hpoId":"HP:0001397","label":"Hepatic steatosis","primary":false},{"hpoId":"HP:0002240","label":"Hepatomegaly","primary":false},{"hpoId":"HP:0001007","label":"Hirsutism","primary":false},{"hpoId":"HP:0003074","label":"Hyperglycemia","primary":false},{"hpoId":"HP:0000842","label":"Hyperinsulinemia","primary":false},{"hpoId":"HP:0000822","label":"Hypertension","primary":false},{"hpoId":"HP:0002155","label":"Hypertriglyceridemia","primary":false},{"hpoId":"HP:0001639","label":"Hypertrophic cardiomyopathy","primary":false},{"hpoId":"HP:0002149","label":"Hyperuricemia","primary":false},{"hpoId":"HP:0000855","label":"Insulin resistance","primary":false},{"hpoId":"HP:0000831","label":"Insulin-resistant diabetes mellitus","primary":false},{"hpoId":"HP:0100578","label":"Lipoatrophy","primary":false},{"hpoId":"HP:0009125","label":"Lipodystrophy","primary":false},{"hpoId":"HP:0000292","label":"Loss of facial adipose tissue","primary":false},{"hpoId":"HP:0009017","label":"Loss of gluteal subcutaneous adipose tissue","primary":false},{"hpoId":"HP:0003635","label":"Loss of subcutaneous adipose tissue in limbs","primary":false},{"hpoId":"HP:0003326","label":"Myalgia","primary":false},{"hpoId":"HP:0003198","label":"Myopathy","primary":false},{"hpoId":"HP:0000876","label":"Oligomenorrhea","primary":false},{"hpoId":"HP:0001733","label":"Pancreatitis","primary":false},{"hpoId":"HP:0000147","label":"Polycystic ovaries","primary":false},{"hpoId":"HP:0000786","label":"Primary amenorrhea","primary":false},{"hpoId":"HP:0001015","label":"Prominent superficial veins","primary":false},{"hpoId":"HP:0007457","label":"Prominent veins on trunk","primary":false},{"hpoId":"HP:0003758","label":"Reduced subcutaneous adipose tissue","primary":false},{"hpoId":"HP:0000869","label":"Secondary amenorrhea","primary":false},{"hpoId":"HP:0003712","label":"Skeletal muscle hypertrophy","primary":false},{"hpoId":"HP:0001744","label":"Splenomegaly","primary":false},{"hpoId":"HP:0000963","label":"Thin skin","primary":false},{"hpoId":"HP:0005978","label":"Type II diabetes mellitus","primary":false},{"hpoId":"HP:0000991","label":"Xanthomatosis","primary":false}],"ledeHtml":"A rare familial partial lipodystrophy characterized by adult onset of distal lipoatrophy with gluteofemoral fat loss, as well as increased fat accumulation in the face and trunk and visceral adiposity. Additional manifestations include diabetes mellitus, atherogenic dyslipidemia, eyelid xanthelasmas, arterial hypertension, cardiovascular disease, hepatic steatosis, acanthosis nigricans on axillae and neck, hirsutism, and muscular hypertrophy of the lower limbs.","mondoId":"MONDO:0011448","node":{"canonicalSlug":"pparg-related-familial-partial-lipodystrophy","comparisons":[],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"summary","independentCorroborationEstablished":false,"matchMethod":"automatic-identity-and-attribution","name":"PPARG-related familial partial lipodystrophy","originalSourceId":"ORPHA:79083","paragraphs":["A rare familial partial lipodystrophy characterized by adult onset of distal lipoatrophy with gluteofemoral fat loss, as well as increased fat accumulation in the face and trunk and visceral adiposity. Additional manifestations include diabetes mellitus, atherogenic dyslipidemia, eyelid xanthelasmas, arterial hypertension, cardiovascular disease, hepatic steatosis, acanthosis nigricans on axillae and neck, hirsutism, and muscular hypertrophy of the lower limbs."],"rawAttribution":"ORPHA:79083","reviewed":null,"scope":"exact","source":"GARD","sourceRelease":"2026-10-25T03:41:40Z","upstream":"ORPHA:79083","url":"https://rarediseases.info.nih.gov/diseases/12600"},"ownColumnKeys":["population-f044b3be35fe8651553b","population-64c4c6b14bd39d97032f"],"publication":"published","relationships":[{"kind":"parent","label":"familial partial lipodystrophy","mondoId":"MONDO:0020088","slug":"familial-partial-lipodystrophy"}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[],"translation":"pending"},"records":[{"frequencyKind":"count","key":"01bd405ba26ae24d6f6fbec9586f9fb8f23ceeed9bf5579299b689b27e296d72","raw":{"aspect":"P","body_system":"endocrine","disease_id":"OMIM:604367","disease_name":"Lipodystrophy, familial partial, type 3","evidence":"PCS","frequency_raw":"3/3","hpo_id":"HP:0000842","is_excluded":false,"label":"Hyperinsulinemia","onset_id":null,"reference":"PMID:10622252","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"039da1492fd4610793b311629f1261a4edfabbc8b564ef844bc8c2f30df34e12","raw":{"aspect":"P","body_system":"endocrine","disease_id":"OMIM:604367","disease_name":"Lipodystrophy, familial partial, type 3","evidence":"PCS","frequency_raw":"3/3","hpo_id":"HP:0005978","is_excluded":false,"label":"Type II diabetes mellitus","onset_id":null,"reference":"PMID:10622252","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"06d9e889f2dcd9815dbd68bb1f4786cda2dfea921189c40a56c8a418eb3067c5","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"ORPHA:79083","disease_name":"PPARG-related familial partial lipodystrophy","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001639","is_excluded":false,"label":"Hypertrophic cardiomyopathy","onset_id":null,"reference":"ORPHA:79083","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"091c38c41b0464bdea66f5e4181287c54c9861293db5e7ff57ec6d3c79a932f4","raw":{"aspect":"P","body_system":"digestive","disease_id":"ORPHA:79083","disease_name":"PPARG-related familial partial lipodystrophy","evidence":"TAS","frequency_raw":"HP:0040284","hpo_id":"HP:0001394","is_excluded":false,"label":"Cirrhosis","onset_id":null,"reference":"ORPHA:79083","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"104960cc32aab18eed246a00f2de5cb2efcbf9f1a0801d49a7b41b5363c1236c","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"ORPHA:79083","disease_name":"PPARG-related familial partial lipodystrophy","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0000869","is_excluded":false,"label":"Secondary amenorrhea","onset_id":null,"reference":"ORPHA:79083","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"114f45ff29ae1795768ae64658a36505d8b7007c0fa71daf46b765067e0eff53","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"OMIM:604367","disease_name":"Lipodystrophy, familial partial, type 3","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0001015","is_excluded":false,"label":"Prominent superficial veins","onset_id":null,"reference":"OMIM:604367","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"17682b1d1c32a9fe55e5f8fd94ddbda8e7faad0dd033c1cf3a4a08b54887a4a1","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"ORPHA:79083","disease_name":"PPARG-related familial partial lipodystrophy","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0000876","is_excluded":false,"label":"Oligomenorrhea","onset_id":null,"reference":"ORPHA:79083","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"1b6c2316e23ba1dac8a92f35b71fba260569e939c4a662ab4d413605174bc676","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:604367","disease_name":"Lipodystrophy, familial partial, type 3","evidence":"PCS","frequency_raw":"3/3","hpo_id":"HP:0000855","is_excluded":false,"label":"Insulin resistance","onset_id":null,"reference":"PMID:10622252","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"1edf2071880c596516a9ddaf5f735129e1ce31aa6818280fe4d41002d215e132","raw":{"aspect":"P","body_system":"other","disease_id":"ORPHA:79083","disease_name":"PPARG-related familial partial lipodystrophy","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0100607","is_excluded":false,"label":"Dysmenorrhea","onset_id":null,"reference":"ORPHA:79083","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"1f880368316f8fe8aeb18600996f30d9f5f8c716efcdc71745be4780426e6d87","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:79083","disease_name":"PPARG-related familial partial lipodystrophy","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0000831","is_excluded":false,"label":"Insulin-resistant diabetes mellitus","onset_id":null,"reference":"ORPHA:79083","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"2135226b5bb9423e580b6afa227d4da02cd1b74e49d889b98747f84561fb92a8","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"ORPHA:79083","disease_name":"PPARG-related familial partial lipodystrophy","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0002621","is_excluded":false,"label":"Atherosclerosis","onset_id":null,"reference":"ORPHA:79083","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"2474e3b860fd0693f4bfafe96079d3a62114ec1e9a583e775d99c133a2ef944d","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:604367","disease_name":"Lipodystrophy, familial partial, type 3","evidence":"PCS","frequency_raw":"2/3","hpo_id":"HP:0003074","is_excluded":false,"label":"Hyperglycemia","onset_id":null,"reference":"PMID:10622252","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"286a6550c66e467b493833a7543a825aab4963f204c8282f602eacf9b9f81dc3","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"ORPHA:79083","disease_name":"PPARG-related familial partial lipodystrophy","evidence":"TAS","frequency_raw":"HP:0040280","hpo_id":"HP:0000822","is_excluded":false,"label":"Hypertension","onset_id":null,"reference":"ORPHA:79083","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"2be79e3c2e0e235672a24d6caa3b01674a65ac45c1bce5dc86c410c391b1c70f","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:604367","disease_name":"Lipodystrophy, familial partial, type 3","evidence":"PCS","frequency_raw":"3/3","hpo_id":"HP:0009125","is_excluded":false,"label":"Lipodystrophy","onset_id":null,"reference":"PMID:10622252","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"2ccda969b0763b1f2469b83c024cd8272aca3a31c3f293336a19f609f9b59f3c","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:79083","disease_name":"PPARG-related familial partial lipodystrophy","evidence":"TAS","frequency_raw":"HP:0040280","hpo_id":"HP:0100578","is_excluded":false,"label":"Lipoatrophy","onset_id":null,"reference":"ORPHA:79083","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"2e5d2680bbc77df96cc4f1c39bd0cecda84f9f995b31cbc6f2398e60f46ae11d","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:79083","disease_name":"PPARG-related familial partial lipodystrophy","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0012084","is_excluded":false,"label":"Abnormality of skeletal muscle fiber size","onset_id":null,"reference":"ORPHA:79083","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"35b28628a38c619e11c5a2d0f7ec771d45ea0c3c642c16c06b37414d645f8fcd","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:79083","disease_name":"PPARG-related familial partial lipodystrophy","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0003712","is_excluded":false,"label":"Skeletal muscle hypertrophy","onset_id":null,"reference":"ORPHA:79083","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"4eff4ceb5694714174fea13ba86f6ec4449cc43a1feaac5e0be1a28af2a073c7","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:604367","disease_name":"Lipodystrophy, familial partial, type 3","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0003635","is_excluded":false,"label":"Loss of subcutaneous adipose tissue in limbs","onset_id":null,"reference":"OMIM:604367","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"5428c25f75ad37a3491a18b087715e141d34b9c70fa28ae69f8fb9e6a35d5f04","raw":{"aspect":"P","body_system":"other","disease_id":"ORPHA:79083","disease_name":"PPARG-related familial partial lipodystrophy","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0003326","is_excluded":false,"label":"Myalgia","onset_id":null,"reference":"ORPHA:79083","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"5a67bc9c4fd51236fa49a121ec7ae927f2274d7f26c50dfae8db336ecd3c2098","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:604367","disease_name":"Lipodystrophy, familial partial, type 3","evidence":"PCS","frequency_raw":"2/3","hpo_id":"HP:0003233","is_excluded":false,"label":"Decreased circulating HDL-C concentration","onset_id":null,"reference":"PMID:10622252","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"63b8974bf0e46301a3d1710ea5e5654e2d4bfbcb4ef62ff902e51096d16f6a56","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"ORPHA:79083","disease_name":"PPARG-related familial partial lipodystrophy","evidence":"TAS","frequency_raw":"HP:0040284","hpo_id":"HP:0007457","is_excluded":false,"label":"Prominent veins on trunk","onset_id":null,"reference":"ORPHA:79083","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"67a8d34a5754e86f4f4d32b22884a3d475c80c81fd5f59bb9532b1537e97ca70","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:79083","disease_name":"PPARG-related familial partial lipodystrophy","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0002155","is_excluded":false,"label":"Hypertriglyceridemia","onset_id":null,"reference":"ORPHA:79083","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"70ebbd641a9bbdffe0f2bc7b52060175826bf57a5c766f928306f4b7d3afd619","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:79083","disease_name":"PPARG-related familial partial lipodystrophy","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0003198","is_excluded":false,"label":"Myopathy","onset_id":null,"reference":"ORPHA:79083","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"725d1e98cd3e87955c2e19b39300cb914780a8437c4fe7c03d907c1600745b39","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:79083","disease_name":"PPARG-related familial partial lipodystrophy","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0000292","is_excluded":false,"label":"Loss of facial adipose tissue","onset_id":null,"reference":"ORPHA:79083","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"77b948ffc5ef92a3112e84b2ecb7cb87ee05b862d69f93bba899f332390c59fd","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:604367","disease_name":"Lipodystrophy, familial partial, type 3","evidence":"PCS","frequency_raw":"3/3","hpo_id":"HP:0002155","is_excluded":false,"label":"Hypertriglyceridemia","onset_id":null,"reference":"PMID:10622252","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"8e8b2f3661644cfd9dcbcd449552c7b765ca2ce08c08b1e607c74bcc16511a1e","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"ORPHA:79083","disease_name":"PPARG-related familial partial lipodystrophy","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0000147","is_excluded":false,"label":"Polycystic ovaries","onset_id":null,"reference":"ORPHA:79083","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"918bb526bade91926f489b62dc52838777b587a1ed9ca89634226e0d1aeec6d7","raw":{"aspect":"P","body_system":"endocrine","disease_id":"OMIM:604367","disease_name":"Lipodystrophy, familial partial, type 3","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0000831","is_excluded":false,"label":"Insulin-resistant diabetes mellitus","onset_id":null,"reference":"OMIM:604367","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"96aea37ed13dc81c692c7aa7c74c9b6a4e7839684d63329a55c62cb1823ec63f","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"ORPHA:79083","disease_name":"PPARG-related familial partial lipodystrophy","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001635","is_excluded":false,"label":"Congestive heart failure","onset_id":null,"reference":"ORPHA:79083","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"9be9f9aca39d7cbbd8d3b3beb21546f9bfb6f899c6743ea56f56d0c02d9641d7","raw":{"aspect":"P","body_system":"digestive","disease_id":"ORPHA:79083","disease_name":"PPARG-related familial partial lipodystrophy","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0002240","is_excluded":false,"label":"Hepatomegaly","onset_id":null,"reference":"ORPHA:79083","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"9f7daaeea4dc5a728eda818ae68a943b4f9ba69dddf5bcb4552d3a5498fa0e20","raw":{"aspect":"P","body_system":"skin","disease_id":"ORPHA:79083","disease_name":"PPARG-related familial partial lipodystrophy","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0000956","is_excluded":false,"label":"Acanthosis nigricans","onset_id":null,"reference":"ORPHA:79083","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"a079aae021ff10d627ed2bc0f1f1064b0232d4b35bea2ced36f8dda0b72d2888","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"OMIM:604367","disease_name":"Lipodystrophy, familial partial, type 3","evidence":"PCS","frequency_raw":"3/3","hpo_id":"HP:0000822","is_excluded":false,"label":"Hypertension","onset_id":null,"reference":"PMID:10622252","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"a09247752a126c7f6b4a45686cdcfd1ad4c637c9102d71e06052f766e46981ea","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:604367","disease_name":"Lipodystrophy, familial partial, type 3","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0002149","is_excluded":false,"label":"Hyperuricemia","onset_id":null,"reference":"OMIM:604367","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"a25c8610ac3de6600801023220e18e3a488d42f9e9b77fd8ffa1841fedf09a6e","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"OMIM:604367","disease_name":"Lipodystrophy, familial partial, type 3","evidence":"IEA","frequency_raw":"HP:0040283","hpo_id":"HP:0000147","is_excluded":false,"label":"Polycystic ovaries","onset_id":null,"reference":"OMIM:604367","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"a58d13c7fe0f7eac3e492b704a58016ff4a133022c07db42f689b5cf26fb6a82","raw":{"aspect":"P","body_system":"skin","disease_id":"ORPHA:79083","disease_name":"PPARG-related familial partial lipodystrophy","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0002230","is_excluded":false,"label":"Generalized hirsutism","onset_id":null,"reference":"ORPHA:79083","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"a70bf04bfa9281394190d33f67a9757eeef3ca5977724568036e87e101f14770","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:79083","disease_name":"PPARG-related familial partial lipodystrophy","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0003635","is_excluded":false,"label":"Loss of subcutaneous adipose tissue in limbs","onset_id":null,"reference":"ORPHA:79083","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"a7614a1ff0160e40842fa7b9509409e10a5e22005f9ed7de0e6dce0e6e8c575d","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:79083","disease_name":"PPARG-related familial partial lipodystrophy","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0003707","is_excluded":false,"label":"Calf muscle pseudohypertrophy","onset_id":null,"reference":"ORPHA:79083","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"a84f7616991c8ed03dc74d602411821ce8945d67af77efdacc6435a9b03bc290","raw":{"aspect":"P","body_system":"skin","disease_id":"OMIM:604367","disease_name":"Lipodystrophy, familial partial, type 3","evidence":"PCS","frequency_raw":"1/3","hpo_id":"HP:0000956","is_excluded":false,"label":"Acanthosis nigricans","onset_id":null,"reference":"PMID:10622252","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"a971afd937503c7df8bdedb9a73d4df023468af59e44aa900d31bac1af93bbc0","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"OMIM:604367","disease_name":"Lipodystrophy, familial partial, type 3","evidence":"PCS","frequency_raw":"1/2","hpo_id":"HP:0000876","is_excluded":false,"label":"Oligomenorrhea","onset_id":null,"reference":"PMID:10622252","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"b0957fc099b4e18771b27f685f2927d8c9bc3c423637c994c4b16eda7c8a198e","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"ORPHA:79083","disease_name":"PPARG-related familial partial lipodystrophy","evidence":"TAS","frequency_raw":"HP:0040284","hpo_id":"HP:0000786","is_excluded":false,"label":"Primary amenorrhea","onset_id":null,"reference":"ORPHA:79083","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"b15f4321743b20caefada1e9f4615d4136e72317c0fbb910ecd65042afbe0345","raw":{"aspect":"P","body_system":"skin","disease_id":"ORPHA:79083","disease_name":"PPARG-related familial partial lipodystrophy","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0000991","is_excluded":false,"label":"Xanthomatosis","onset_id":null,"reference":"ORPHA:79083","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"b1c78c8bd99080fb1b663174749bbf2a0468e810a0b1effbd4436332bdceeb0d","raw":{"aspect":"P","body_system":"digestive","disease_id":"OMIM:604367","disease_name":"Lipodystrophy, familial partial, type 3","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0001394","is_excluded":false,"label":"Cirrhosis","onset_id":null,"reference":"OMIM:604367","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"b33d8bfd15095244997f68970feb08800a22f5dbec0bbe133d65b309d0aad9a0","raw":{"aspect":"P","body_system":"digestive","disease_id":"ORPHA:79083","disease_name":"PPARG-related familial partial lipodystrophy","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001744","is_excluded":false,"label":"Splenomegaly","onset_id":null,"reference":"ORPHA:79083","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"b670feebb645eadffda03809de0dd4c08731069042ac12dfbd939694c7156039","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:604367","disease_name":"Lipodystrophy, familial partial, type 3","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0009017","is_excluded":false,"label":"Loss of gluteal subcutaneous adipose tissue","onset_id":null,"reference":"OMIM:604367","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"bdef78f9549d6cf6d625cea6d1c82a43d7505d99b469b403da44257b1a87739e","raw":{"aspect":"P","body_system":"skin","disease_id":"ORPHA:79083","disease_name":"PPARG-related familial partial lipodystrophy","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0008065","is_excluded":false,"label":"Aplasia/Hypoplasia of the skin","onset_id":null,"reference":"ORPHA:79083","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"c0fb4b9fd4b30dbd2ac1a24bdbe09a3af161efb5e751f5fa6afcec3894977975","raw":{"aspect":"P","body_system":"skin","disease_id":"OMIM:604367","disease_name":"Lipodystrophy, familial partial, type 3","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0001007","is_excluded":false,"label":"Hirsutism","onset_id":null,"reference":"OMIM:604367","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"cca44d37ac910aad8fc61c0e71469a89965e79b7d01d354bbd90dd8019e4d1ca","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:604367","disease_name":"Lipodystrophy, familial partial, type 3","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0003758","is_excluded":false,"label":"Reduced subcutaneous adipose tissue","onset_id":null,"reference":"OMIM:604367","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"count","key":"e081feec23e3f1c4792e73ac452180a512cb238d41df6919af430e584f5f1ead","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"OMIM:604367","disease_name":"Lipodystrophy, familial partial, type 3","evidence":"PCS","frequency_raw":"1/2","hpo_id":"HP:0000786","is_excluded":false,"label":"Primary amenorrhea","onset_id":null,"reference":"PMID:10622252","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"e12eb4b393614d9d67c62d0cb2fd66208c6065b94a71b611f31e931cb37dfb51","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:604367","disease_name":"Lipodystrophy, familial partial, type 3","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0001397","is_excluded":false,"label":"Hepatic steatosis","onset_id":null,"reference":"OMIM:604367","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"e2aced6f2aeee2e1c2a2828ef09dfaa0a120a0245265111b2ddb06d29a9188ee","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:79083","disease_name":"PPARG-related familial partial lipodystrophy","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0000819","is_excluded":false,"label":"Diabetes mellitus","onset_id":null,"reference":"ORPHA:79083","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"e7d4949cebf9365d07728cd8a4408cf38576135b85853d11ca5f4ad61d4a9ae6","raw":{"aspect":"P","body_system":"skin","disease_id":"ORPHA:79083","disease_name":"PPARG-related familial partial lipodystrophy","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0000963","is_excluded":false,"label":"Thin skin","onset_id":null,"reference":"ORPHA:79083","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"f819cc40be6b33af77e7366eb46b9e9964f40d3f8ad7cf850d8fc744e7a28120","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:79083","disease_name":"PPARG-related familial partial lipodystrophy","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0002149","is_excluded":false,"label":"Hyperuricemia","onset_id":null,"reference":"ORPHA:79083","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"f9415006beee712f4b23bd78619982ee8ab60854bd6d48ee02972c64f688080d","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:79083","disease_name":"PPARG-related familial partial lipodystrophy","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001397","is_excluded":false,"label":"Hepatic steatosis","onset_id":null,"reference":"ORPHA:79083","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"fb0d571f868d4bc6c4e0a8083b406338e8e0ebbfe4cfa330631c6a962dbede81","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"ORPHA:79083","disease_name":"PPARG-related familial partial lipodystrophy","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001677","is_excluded":false,"label":"Coronary artery atherosclerosis","onset_id":null,"reference":"ORPHA:79083","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"fbc6dc1611116d3f72402396dab386daabc569424f647b5271e5e83bc134e0be","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:79083","disease_name":"PPARG-related familial partial lipodystrophy","evidence":"TAS","frequency_raw":"HP:0040280","hpo_id":"HP:0000855","is_excluded":false,"label":"Insulin resistance","onset_id":null,"reference":"ORPHA:79083","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"fc870822c146f97b04590fa599c4f242531380e132623554626760b9f33cecca","raw":{"aspect":"P","body_system":"digestive","disease_id":"ORPHA:79083","disease_name":"PPARG-related familial partial lipodystrophy","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001733","is_excluded":false,"label":"Pancreatitis","onset_id":null,"reference":"ORPHA:79083","source_release":"2026-06-23"},"sourceGroups":["orphanet"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/12600\" rel=\"noreferrer\">GARD</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>summary</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>automatic-identity-and-attribution</dd><dt>Upstream attribution</dt><dd>ORPHA:79083</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>A rare familial partial lipodystrophy characterized by adult onset of distal lipoatrophy with gluteofemoral fat loss, as well as increased fat accumulation in the face and trunk and visceral adiposity. Additional manifestations include diabetes mellitus, atherogenic dyslipidemia, eyelid xanthelasmas, arterial hypertension, cardiovascular disease, hepatic steatosis, acanthosis nigricans on axillae and neck, hirsutism, and muscular hypertrophy of the lower limbs.</p><p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/12600\" rel=\"noreferrer\">GARD</a></p>","key":"overview","title":"Overview"}],"sharedSources":[],"slug":"pparg-related-familial-partial-lipodystrophy","sourceDocuments":[{"name":"GARD: PPARG-related familial partial lipodystrophy","reviewed":null,"source_release":"2026-10-25T03:41:40Z","url":"https://rarediseases.info.nih.gov/diseases/12600"}],"sourceNote":"","synonyms":["familial partial lipodystrophy associated with PPARG mutations","familial partial lipodystrophy type 3","FPLD3","lipodystrophy, familial partial, type 3","PPARG-related FPLD"],"takeawayHtml":"","title":"PPARG-related familial partial lipodystrophy"},"schemaVersion":1}
